Reply
1. Propofol (10 mg/ ml in 20 ml and 20 mg/ ml in 50 ml) Injections (emulsion). The required quantity is 2,500 units and 3,000 units respectively.
2. Ambroxol Hydrochloride (15 mg/ 2 ml) Injections. The required quantity is 5,000 units.
3. Sodium Glycerophosphate (216 mg/ ml) Infusion. The required quantity is 1,000 units.
4. Canrenone Potassium (20 mg/ ml in 10 ml) Injection Solution. The required quantity is 50 units.
5. Potassium Chloride (391 mg) Prolonged-Release Tablets in a pack of 30. The required quantity is 3,000 units.
6. Calcium Carbonate (400 mg) Hard Capsules in a pack of 100. The required quantity is 2,000 units.
7. Ceftriaxone (2 g) Solution for Preparation of Injection. The required quantity is 10,000 units.
8. Ceftazidime (2 g) + Avibactam (0.5 g) Infusion Solution. The required quantity is 210 units.
9. Mannitol (150 mg/ ml and 200 mg/ ml) for Infusion. The required quantity is 6,000 units and 500 units respectively.
10. Paracetamol (10 mg/ ml) for Infusion. The required quantity is 500 units.
vishvesh.shaishav@gmail.com
We are focussed on developing new manufacturing technologies, including custom synthesis of new moleculepharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, pharmaceutical pellets,additives, contract manufacturing, chemicals. We began in the field of specialty intermediates for pharmaceutical applications and developed our own purification technologies for manufacturing highly pure intermediates. And Pharmaceutical API At a later stage, we integrated forward to manufacture finished formulations for both veterinary and human consumption. Due to our completely integrated operations in the pharmaceutical sector, we continuously learn about the quality parameters for an API based on the performance of the finished formulation in order to quality their Bioequivalence Studies.
We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.
Our focus lies in developing new production technologies with a keen interest in frugal innovation in order to gain a competitive edge over others. We specialize in the custom synthesis of molecules and work with many reputed companies around the world on an OEM basis.pharmaceutical pellets,Intermidiates
Our finished formulations from WHO-GMP and EU-GMP units are registered/being registered in 26 countries within Asia, Europe, North America, Latin America and Africa continents including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad, Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.
vishvesh.shaishav@gmail.com
rama.belagali@zenvisionpharma.com
we are working as CRO.
We are in to the F&D product
vishvesh.shaishav@gmail.com
We are focussed on developing new manufacturing technologies, including custom synthesis of new moleculepharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, pharmaceutical pellets,additives, contract manufacturing, chemicals. We began in the field of specialty intermediates for pharmaceutical applications and developed our own purification technologies for manufacturing highly pure intermediates. And Pharmaceutical API At a later stage, we integrated forward to manufacture finished formulations for both veterinary and human consumption. Due to our completely integrated operations in the pharmaceutical sector, we continuously learn about the quality parameters for an API based on the performance of the finished formulation in order to quality their Bioequivalence Studies.
We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.
Our focus lies in developing new production technologies with a keen interest in frugal innovation in order to gain a competitive edge over others. We specialize in the custom synthesis of molecules and work with many reputed companies around the world on an OEM basis.pharmaceutical pellets,Intermidiates
Our finished formulations from WHO-GMP and EU-GMP units are registered/being registered in 26 countries within Asia, Europe, North America, Latin America and Africa continents including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad, Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.
vishvesh.shaishav@gmail.com
jgq@yangzijiang.com
jgq@yangzijiang.com
I am Justin from Yangtze River Pharmaceutical Group in China
APIs and FDF can be manufactured by our company.
We can also CMO
If you need them, please contact me by Tel., WhatsApp and Wechat: +86 15261051195
Email: jgq@yangzijiang.com
sales@fapharm.com
We produce Ambroxol Hydrochloride
Injection. Fuan Pharmaceutical (Group) Co., LTD. is specilized in intermediates and APIs and finished products.
It is a large scaled modern pharmaceutical group (Listed in Shenzhen :Stock code 300194) with 9 subsidarities, integrating R&D, Production and Sales.
sales@fapharm.com
We produce Ambroxol Hydrochloride
Injection. Fuan Pharmaceutical (Group) Co., LTD. is specilized in intermediates and APIs and finished products.
It is a large scaled modern pharmaceutical group (Listed in Shenzhen :Stock code 300194) with 9 subsidarities, integrating R&D, Production and Sales.
sales@fapharm.com
We produce Ambroxol Hydrochloride
Injection. Fuan Pharmaceutical (Group) Co., LTD. is specilized in intermediates and APIs and finished products.
It is a large scaled modern pharmaceutical group (Listed in Shenzhen :Stock code 300194) with 9 subsidarities, integrating R&D, Production and Sales.
export@healthpharma.in
Dear Sir,
Greetings from Health Pharma...!!!
We can support you with your requirements. Kindly request you to send email for detailed information.
Looking forward to your positive response.
Thanks...!!!
